The knockdown of TWIST1 from the cell lines of ALK+ ALCL increased their sensitivity to Crizotinib, a tyrosine kinase inhibitor, and reduced the invasiveness. The gene discussed is TWIST1; the disease is anaplastic large cell lymphoma.